Vir Biotechnology (VIR) Amortizatization of Intangibles (2018 - 2026)
Vir Biotechnology recorded quarterly Amortizatization of Intangibles of -$394000.0 in Q1 2026, up 74.56% quarter-over-quarter from -$1.5 million in Q4 2025, and up 90.36% year-over-year from -$206971.5 in Q1 2025.
Vir Biotechnology's Amortizatization of Intangibles history runs 9 years deep, the most recent figure standing at -$394000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles rose 90.36% year-over-year to -$394000.0; the TTM figure through Mar 2026 stood at -$5.8 million (up 37.51% YoY), while the FY2025 annual figure was -$9.5 million, down 75.54% from the prior year.
- Amortizatization of Intangibles came in at -$394000.0 for Q1 2026 at Vir Biotechnology, up from -$1.5 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $9.4 million in Q1 2023 to a low of -$4.1 million in Q1 2025.
- A 5-year average of $140235.3 and a median of -$1.3 million in 2025 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles surged 6941.35% in 2023 and slumped 1618.07% in 2025, its largest moves.
- Vir Biotechnology's Amortizatization of Intangibles stood at $8.5 million in 2022, then sank by 115.81% to -$1.4 million in 2023, then slumped by 60.47% to -$2.2 million in 2024, then rose by 28.55% to -$1.5 million in 2025, then jumped by 74.56% to -$394000.0 in 2026.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered -$394000.0, -$1.5 million, and -$1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Vir Biotechnology | 1.33 Bn | 1.33 Bn | - | -394,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -394,000.00 |
| Mar 31, 2026 | -394,000.00 |
| Dec 31, 2025 | -1.55 Mn |
| Dec 31, 2025 | -1.55 Mn |
| Sep 30, 2025 | -1.32 Mn |
| Sep 30, 2025 | -1.32 Mn |
| Jun 30, 2025 | -2.52 Mn |
| Jun 30, 2025 | -2.52 Mn |
| Mar 31, 2025 | -4.09 Mn |
| Mar 31, 2025 | -4.09 Mn |
| Dec 31, 2024 | -2.17 Mn |
| Dec 31, 2024 | -2.17 Mn |
| Sep 30, 2024 | -354,000.00 |
| Sep 30, 2024 | -354,000.00 |
| Jun 30, 2024 | -2.64 Mn |
| Jun 30, 2024 | -2.64 Mn |
| Mar 31, 2024 | -238,000.00 |
| Mar 31, 2024 | -238,000.00 |
| Dec 31, 2023 | -1.35 Mn |
| Dec 31, 2023 | -1.35 Mn |
| Sep 30, 2023 | -2.31 Mn |
| Sep 30, 2023 | -2.31 Mn |
| Jun 30, 2023 | 3.00 Mn |
| Jun 30, 2023 | 3.00 Mn |
| Mar 31, 2023 | 9.37 Mn |
| Mar 31, 2023 | 9.37 Mn |
| Dec 31, 2022 | 8.54 Mn |
| Dec 31, 2022 | 8.54 Mn |
| Sep 30, 2022 | 2.13 Mn |
| Sep 30, 2022 | 2.13 Mn |
| Jun 30, 2022 | -1.87 Mn |
| Jun 30, 2022 | -1.87 Mn |
| Mar 31, 2022 | 133,000.00 |
| Mar 31, 2022 | 133,000.00 |
| Dec 31, 2021 | -155,000.00 |
| Dec 31, 2021 | -155,000.00 |
| Sep 30, 2021 | 161,000.00 |
| Sep 30, 2021 | 161,000.00 |
| Jun 30, 2021 | 647,000.00 |
| Jun 30, 2021 | 647,000.00 |
| Mar 31, 2021 | -409,000.00 |
| Mar 31, 2021 | -409,000.00 |
| Dec 31, 2020 | 124,000.00 |
| Dec 31, 2020 | 124,000.00 |
| Sep 30, 2020 | 300,000.00 |
| Sep 30, 2020 | 300,000.00 |
| Jun 30, 2020 | 1.17 Mn |
| Jun 30, 2020 | 1.17 Mn |
| Mar 31, 2020 | -562,000.00 |
| Mar 31, 2020 | -562,000.00 |
| Dec 31, 2019 | -739,000.00 |
| Dec 31, 2019 | -739,000.00 |
| Sep 30, 2019 | 300,000.00 |
| Sep 30, 2019 | 300,000.00 |
| Jun 30, 2019 | 306,000.00 |
| Jun 30, 2019 | 306,000.00 |
| Mar 31, 2019 | 306,000.00 |
| Mar 31, 2019 | 306,000.00 |
| Dec 31, 2018 | -505,000.00 |
| Dec 31, 2018 | -505,000.00 |